ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 22 filers reported holding ENVVENO MEDICAL CORPORATION in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,120 | +75.1% | 2,063 | +0.0% | 0.00% | – |
| Q2 2023 | $6,351 | -34.1% | 2,062 | +0.1% | 0.00% | – |
| Q1 2023 | $9,641 | -8.2% | 2,060 | +0.0% | 0.00% | – |
| Q4 2022 | $10,501 | -19.2% | 2,059 | +0.1% | 0.00% | – |
| Q3 2022 | $13,000 | +62.5% | 2,057 | +0.4% | 0.00% | – |
| Q2 2022 | $8,000 | -38.5% | 2,049 | +0.2% | 0.00% | – |
| Q1 2022 | $13,000 | 0.0% | 2,045 | 0.0% | 0.00% | – |
| Q4 2021 | $13,000 | – | 2,045 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 401,200 | $1,517,000 | 2.12% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 219,180 | $829,000 | 0.14% |
| Perceptive Advisors | 781,615 | $2,954,000 | 0.09% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 24,000 | $91,000 | 0.02% |
| UBS OCONNOR LLC | 118,113 | $446,000,000 | 0.01% |
| Sepio Capital, LP | 10,800 | $41,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,049 | $8,000 | 0.00% |
| NORTHERN TRUST CORP | 13,906 | $53,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 81,723 | $308,000 | 0.00% |